The AAOP's new training platform, developed with Alchemy Vision, enhances practice efficiency and patient care through ...

Epion Therapeutics announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation to ...

The US Food and Drug Administration (FDA) has selected Abeona Therapeutics’ ABO-503 gene therapy for X-linked retinoschisis ...

Pediatric progressive myopia is a growing global public health concern, linked to serious ocular complications including ...

The Polaris platform is the world’s first AI-supported and robotics-enabled surgical system developed specifically for ...

REGENXBIO completed enrollment in its ATMOSPHERE and ASCENT trials that will be evaluating surabgene lomparvovec (sura-vec, ...

Considering this knowledge of the retina, the investigators conducted a study in which the goals were to detect and quantify ...

Early and aggressive treatment of dry eye disease can prevent progression and preserve ocular health, especially in glaucoma ...

The US Food and Drug Administration (FDA) has approved Celltrion’s aflibercept-boav (EYDENZELT) biosimilar referencing ...

The jump from training to independent practice is a uniquely personal experience. For some, it feels like a natural next step ...

Privosegtor (also known as OCS-05) is a “first-in-class peptoid small molecule” for neuroprotective therapy for acute optic ...

From early experiences in India to fellowship training at Wills Eye Hospital, Dr. Ansari discusses how ophthalmologists can ...